2022-04-29 16:00Financial Performance - The company's operating revenue for Q1 2022 was RMB 473,617,820.88, representing a year-on-year increase of 23.79%[2] - The net profit attributable to shareholders decreased by 37.17% to RMB 60,941,331.70, primarily due to production challenges and fixed cost allocation[5] - The net profit for Q1 2022 was CNY 63,476,862.60, a decrease of 36.2% compared to CNY 99,315,085.73 in Q1 2021[15] - The basic and diluted earnings per share were both RMB 0.35, reflecting a decline of 36.36%[2] - Basic and diluted earnings per share for Q1 2022 were both CNY 0.35, down from CNY 0.55 in Q1 2021[16] - The total comprehensive income for Q1 2022 was CNY -12,480,097.16, contrasting with CNY 120,373,389.52 in Q1 2021[15] Cash Flow and Liquidity - The net cash flow from operating activities fell by 71.36% to RMB 4,470,962.15, influenced by increased wage payments and raw material procurement costs[7] - Cash flow from operating activities generated CNY 4,470,962.15, a decline of 71.4% from CNY 15,609,445.06 in the previous year[16] - Cash and cash equivalents as of March 31, 2022, were CNY 2,697,254,015.40, down from CNY 2,901,402,136.28 at the end of 2021[11] - Cash and cash equivalents at the end of Q1 2022 totaled CNY 988,400,664.79, down from CNY 1,327,887,460.94 at the beginning of the period[17] - The company maintained a strong liquidity position with current assets totaling CNY 3,585,776,992.44 as of March 31, 2022[11] Assets and Liabilities - Total assets at the end of the reporting period were RMB 6,854,436,764.22, a decrease of 1.38% compared to the end of the previous year[3] - Total assets as of March 31, 2022, amounted to CNY 6,854,436,764.22, a slight decrease from CNY 6,950,355,416.19 at the end of 2021[12] - Total liabilities as of March 31, 2022, were CNY 835,467,406.99, down from CNY 890,070,458.09 at the end of 2021[12] Research and Development - R&D investment totaled RMB 45,520,090.97, accounting for 9.61% of operating revenue, an increase of 0.06 percentage points year-on-year[3] - Research and development expenses increased to CNY 45,520,090.97 in Q1 2022, compared to CNY 36,527,079.45 in Q1 2021, reflecting a growth of 24.5%[13] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 11,295[8] - The largest shareholder, Jiang Wei, held 25.28% of the shares, totaling 44,449,000 shares[8] Other Financial Metrics - The weighted average return on net assets was 1.08%, down by 0.67 percentage points[3] - The company reported non-recurring gains of RMB 1,858,769.15 for the period[4] - The company reported a net profit margin improvement, with net profit for Q1 2022 reflecting operational efficiency gains[13] - Inventory as of March 31, 2022, was CNY 376,825,300.32, an increase from CNY 354,765,098.16 at the end of 2021[11] - The company reported a decrease in other comprehensive income after tax, amounting to CNY -75,956,959.76 in Q1 2022, compared to CNY 21,058,303.79 in Q1 2021[15] - Investment income from associates and joint ventures was CNY 1,200,000.00 in Q1 2022, a substantial increase from CNY 138,062.36 in Q1 2021[15] Future Outlook - The company plans to continue investing in new product development and market expansion strategies in the upcoming quarters[10]